Extended Pouch Roux-en-Y Gastric Bypass Study
Restrictive Extended Pouch in Roux-en-Y Gastric Bypass: a Prospective Randomized Control Trial
1 other identifier
interventional
130
1 country
1
Brief Summary
Morbid obesity is an increasing medical problem in the western countries. It's related to comorbidities as diabetes mellitus, hypertension, OSAS, arthrosis and hypercholesterolemia. The Roux-en-Y Gastric Bypass (RYGB) is an effective surgical therapy for morbidly obese patients. A part of these patients will have disappointing results, and have weight regain on the long term. Some studies show more weight reduction by increasing the biliopancreatic limb in patients with morbid obesity. The objective of this study is to investigate the effect of a restrictive/extended pouch on weight reduction in morbidly obese patients undergoing RYGB-surgery. We hypothesize that the restrictive/extended pouch results in more weight reduction. The study design is a prospective, randomized control trial. The patients will be randomized in 2 groups: a standard RYGB (normal pouch) and restrictive/extended pouch RYGB.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 13, 2014
CompletedFirst Posted
Study publicly available on registry
August 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedJune 20, 2024
June 1, 2024
1 year
August 13, 2014
June 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight reduction
Excess weight loss (%EWL)
2 years
Secondary Outcomes (2)
Change in comorbidities
2 years
Change in comorbidities
2 years
Other Outcomes (2)
Complications
2 years
Quality of life
2 years
Study Arms (2)
Standard RYGB
ACTIVE COMPARATORStandard RYGB
Extended Pouch RYGB
EXPERIMENTALRestrictive/extended pouch RYGB
Interventions
Eligibility Criteria
You may qualify if:
- Patient eligible for bariatric surgery according Fried guidelines
- Primary Gastric bypass
- BMI 35 - 40 with a comorbidity
- or BMI \> 40
You may not qualify if:
- Patients with language problems that interveins to follow medical advises
- Genetic diseases that intervens to follow medical advises
- Chronic bowel diseases
- Nephrologic (MDRD \<30) of liver diseases (AST/ALT more than twice the norm)
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rijnstate Hospital
Arnhem, Gelderland, 6800WC, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Homan, MD
Rijnstate Hospital Arnhem
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2014
First Posted
August 18, 2014
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2018
Last Updated
June 20, 2024
Record last verified: 2024-06